A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

The findings have been reported in Nature. Researchers have found that antiviral enzymes, which can mutate the genomes of ...

The holidays are about more than just the food on our plates—they’re about the joy, connection, and tradition we share around the table. Join a registered dietitian to discover how you can savor the ...

As a patient with chronic lymphocytic leukemia, I recently gleaned three new insights from my oncologist and phlebotomist.

(BRPROUD) — A fundraiser for an Ascension Parish dispatcher battling breast cancer has been set for Friday ... The sheriff’s office will sell $10 Jambalaya plates which can be picked up ...

But these remarkable cells appear to be outwitted by cancer cells, which evade detection and grow uncontrollably. CAR-T is a type of immunotherapy that provides a way round this by turning a patient’s ...

Female bladder cancer patients undergoing bladder-sparing therapies often experience minimal disruption to sexual health compared to those undergoing cystectomy. The study underscores the need for ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Gilead is with­draw­ing the ac­cel­er­at­ed ap­proval for its block­buster an­ti­body-drug con­ju­gate Trodelvy for blad­der can­cer af­ter it failed to im­prove sur­vival odds ...